Understanding the Art & Science of TIL Therapy by Reframing Immunity & Resistance

Time: 9:00 am
day: Conference Day Two AM

Details:

• Reframing tumor immunity with a new model: I before E: inflammation, inception, initiation, followed by immune editing with elimination, equilibrium, and escape
• Introducing pre- and post-TIL strategies to enhance the number and quality of TIL and overcome resistance
• Emphasizing the bespoke nature of TIL as a scientific advantage, and a strength

Speakers:

Michael Lotze Michael T. Lotze, MD, FACS is Professor of Surgery, Immunology, and Bioengineering; Director of the DAMP Laboratories at the UPMC Hillman Cancer Center; and Sr. Read more